- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers ; volume:22 ; number:1 ; day:19 ; month:9 ; year:2024 ; pages:1-7 ; date:12.2024
Hereditary cancer in clinical practice ; 22, Heft 1 (19.9.2024), 1-7, 12.2024
- Creator
-
Matuszczak, Milena
Kiljańczyk, Adam
Marciniak, Wojciech
Derkacz, Róża
Stempa, Klaudia
Baszuk, Piotr
Bryśkiewicz, Marta
Cybulski, Cezary
Dębniak, Tadeusz
Jacek, Gronwald
Huzarski, Tomasz
Lener, Marcin
Jakubowska, Anna
Pietrzak, Sandra
Szwiec, Marek
Stawicka-Niełacna, Małgorzata
Godlewski, Dariusz
Prusaczyk, Artur
Jasiewicz, Andrzej
Kluz, Tomasz
Tomiczek-Szwiec, Joanna
Kilar-Kobierzycka, Ewa
Siołek, Monika
Posmyk, Renata
Jarkiewicz-Tretyn, Joanna
Scott, Rodney
Narod, Steven
Lubiński, Jan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13053-024-00291-7
- URN
-
urn:nbn:de:101:1-2412022146502.128630738109
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Matuszczak, Milena
- Kiljańczyk, Adam
- Marciniak, Wojciech
- Derkacz, Róża
- Stempa, Klaudia
- Baszuk, Piotr
- Bryśkiewicz, Marta
- Cybulski, Cezary
- Dębniak, Tadeusz
- Jacek, Gronwald
- Huzarski, Tomasz
- Lener, Marcin
- Jakubowska, Anna
- Pietrzak, Sandra
- Szwiec, Marek
- Stawicka-Niełacna, Małgorzata
- Godlewski, Dariusz
- Prusaczyk, Artur
- Jasiewicz, Andrzej
- Kluz, Tomasz
- Tomiczek-Szwiec, Joanna
- Kilar-Kobierzycka, Ewa
- Siołek, Monika
- Posmyk, Renata
- Jarkiewicz-Tretyn, Joanna
- Scott, Rodney
- Narod, Steven
- Lubiński, Jan
- SpringerLink (Online service)
Other Objects (12)
Selenium and genotypes as marker of risk in BRCA1 mutation carriers
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Selenium and genotypes as marker of risk in BRCA1 mutation carriers
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Selenium and genotypes as marker of risk in BRCA1 mutation carriers
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease